{
"info": {
"nct_id": "NCT03196180",
"official_title": "A Feasibility Trial of Alternating Intravaginal Application of 5-Fluorouracil and Imiquimod for Treatment of High-Grade Cervical Squamous Intraepithelial Lesions",
"inclusion_criteria": "* Women with biopsy confirmed high grade cervical squamous intraepithelial lesions (i.e., cervical squamous intraepithelial neoplasia 3 [CIN3] lesions, and cervical squamous epithelial neoplasia 2 [CIN2] lesions with diagnosis confirmed by positive p16 immunohistochemistry staining) within 12 weeks of baseline visit\n* Karnofsky >= 70%\n* Leukocytes >= 3,000/microliter\n* Absolute neutrophil count >= 1,500/microliter\n* Platelets >= 100,000/microliter\n* Serum creatinine =< the upper institutional limits\n* Participants must have a negative human immunodeficiency virus (HIV) antibody/antigen test and negative Chlamydia (C.) trachomatis/Neisseria (N.) gonorrhea nucleic acid amplification test (NAAT)\n* Agree to use an effective form of contraception; the effects of intravaginal 5-fluorocuracil and imiquimod on the developing human fetus at the recommended therapeutic dose are unknown; for this reason and because 5- fluorouracil is known to be teratogenic, women of child-bearing potential must agree to use adequate dual methods of contraception (hormonal method of birth control, intrauterine device, or tubal ligation - plus condoms) or abstinence prior to study entry and for the duration of study participation; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately\n* Ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 45 Years",
"exclusion_criteria": "* Women treated previously with 5-fluorouracil or imiquimod or other medications for high-grade squamous intraepithelial lesions will be excluded from the study\n* Concurrent vaginal, vulvar, anal lesions or symptomatic infections\n* Pregnant or planning pregnancy within the next 6 months, or breastfeeding; pregnant women are excluded from this study because 5-fluorouracil is an antimetabolite with the potential for teratogenic effects; because there is an unknown but potential risk for adverse events (AEs) in nursing infants secondary to treatment of the mother with 5-fluorouracil, breastfeeding should be discontinued if the mother is treated with 5-fluorouracil\n* Inability to speak or read English or Spanish\n* Prior hysterectomy\n* Use of anticoagulant medications\n* Subjects who have a known immunocompromised condition (HIV positive [+], use of immunosuppressive medications or systemic steroids, organ transplant recipients) or autoimmune conditions (e.g. psoriasis, rheumatoid arthritis or other known autoimmune conditions)\n* Evidence of invasive anal, vulva, vaginal, or cervical carcinoma; prior loop electrosurgical excision procedure (LEEP) or ablative treatment within 6 months prior to study entry; other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years\n* Pathologic findings consistent with\n\n * Atypical endometrial cells or serious glandular-cell atypia (atypical glandular cells, favor neoplasia cytology diagnosis)\n * Evidence of cervical carcinoma on Pap smear or biopsy\n * More than two cervical quadrants of CIN 3 as visualized by colposcopy\n * Nonvisual squamous columnar junction on colposcopy with no concurrent endocervical sampling performed\n* Use of other investigational agents within 6 months prior to enrollment\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 5-fluorouracil or imiquimod\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection (other than human papilloma virus [HPV]), symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements\n* Subjects with known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Women with biopsy confirmed high grade cervical squamous intraepithelial lesions (i.e., cervical squamous intraepithelial neoplasia 3 [CIN3] lesions, and cervical squamous epithelial neoplasia 2 [CIN2] lesions with diagnosis confirmed by positive p16 immunohistochemistry staining) within 12 weeks of baseline visit",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirement": {
"requirement_type": "expected gender",
"expected_value": "female"
}
},
{
"exact_snippets": "biopsy confirmed high grade cervical squamous intraepithelial lesions",
"criterion": "cervical squamous intraepithelial lesions",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "biopsy"
}
},
{
"exact_snippets": "cervical squamous intraepithelial neoplasia 3 [CIN3] lesions",
"criterion": "CIN3 lesions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "cervical squamous epithelial neoplasia 2 [CIN2] lesions with diagnosis confirmed by positive p16 immunohistochemistry staining",
"criterion": "CIN2 lesions",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "positive p16 immunohistochemistry staining"
}
},
{
"exact_snippets": "within 12 weeks of baseline visit",
"criterion": "time since diagnosis",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 12,
"unit": "weeks"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirement": {
"requirement_type": "expected gender",
"expected_value": "female"
}
},
{
"exact_snippets": "biopsy confirmed high grade cervical squamous intraepithelial lesions",
"criterion": "cervical squamous intraepithelial lesions",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "biopsy"
}
}
]
},
{
"or_criteria": [
{
"exact_snippets": "cervical squamous intraepithelial neoplasia 3 [CIN3] lesions",
"criterion": "CIN3 lesions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "cervical squamous epithelial neoplasia 2 [CIN2] lesions with diagnosis confirmed by positive p16 immunohistochemistry staining",
"criterion": "CIN2 lesions",
"requirement": {
"requirement_type": "confirmation method",
"expected_value": "positive p16 immunohistochemistry staining"
}
}
]
}
]
},
{
"exact_snippets": "within 12 weeks of baseline visit",
"criterion": "time since diagnosis",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 12,
"unit": "weeks"
}
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Karnofsky >= 70%",
"criterions": [
{
"exact_snippets": "Karnofsky >= 70%",
"criterion": "Karnofsky",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Karnofsky >= 70%",
"criterion": "Karnofsky",
"requirement": {
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 70,
"unit": "%"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Leukocytes >= 3,000/microliter",
"criterions": [
{
"exact_snippets": "Leukocytes >= 3,000/microliter",
"criterion": "leukocytes",
"requirement": {
"requirement_type": "count",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "microliter"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Leukocytes >= 3,000/microliter",
"criterion": "leukocytes",
"requirement": {
"requirement_type": "count",
"expected_value": {
"operator": ">=",
"value": 3000,
"unit": "microliter"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Absolute neutrophil count >= 1,500/microliter",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count >= 1,500/microliter",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "microliter"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Absolute neutrophil count >= 1,500/microliter",
"criterion": "absolute neutrophil count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "microliter"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Platelets >= 100,000/microliter",
"criterions": [
{
"exact_snippets": "Platelets >= 100,000/microliter",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "microliter"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Platelets >= 100,000/microliter",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "microliter"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Serum creatinine =< the upper institutional limits",
"criterions": [
{
"exact_snippets": "Serum creatinine =< the upper institutional limits",
"criterion": "serum creatinine",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "upper institutional limits"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Serum creatinine =< the upper institutional limits",
"criterion": "serum creatinine",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "upper institutional limits"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Participants must have a negative human immunodeficiency virus (HIV) antibody/antigen test and negative Chlamydia (C.) trachomatis/Neisseria (N.) gonorrhea nucleic acid amplification test (NAAT)",
"criterions": [
{
"exact_snippets": "negative human immunodeficiency virus (HIV) antibody/antigen test",
"criterion": "HIV antibody/antigen test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative Chlamydia (C.) trachomatis/Neisseria (N.) gonorrhea nucleic acid amplification test (NAAT)",
"criterion": "Chlamydia trachomatis/Neisseria gonorrhea NAAT",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "negative human immunodeficiency virus (HIV) antibody/antigen test",
"criterion": "HIV antibody/antigen test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative Chlamydia (C.) trachomatis/Neisseria (N.) gonorrhea nucleic acid amplification test (NAAT)",
"criterion": "Chlamydia trachomatis/Neisseria gonorrhea NAAT",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
}
]
}
},
{
"identified_line": {
"line": "* Ability to understand and the willingness to sign a written informed consent document",
"criterions": [
{
"exact_snippets": "Ability to understand",
"criterion": "cognitive ability",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "willingness to sign a written informed consent document",
"criterion": "willingness to consent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Ability to understand",
"criterion": "cognitive ability",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "willingness to sign a written informed consent document",
"criterion": "willingness to consent",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "N/A",
"expected_value": "female"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirement": {
"requirement_type": "N/A",
"expected_value": "female"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 45 Years",
"criterions": [
{
"exact_snippets": "maximum age of 45 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 45,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 45 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 45,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Women treated previously with 5-fluorouracil or imiquimod or other medications for high-grade squamous intraepithelial lesions will be excluded from the study",
"criterions": [
{
"exact_snippets": "Women treated previously with 5-fluorouracil",
"criterion": "previous treatment with 5-fluorouracil",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Women treated previously with ... imiquimod",
"criterion": "previous treatment with imiquimod",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Women treated previously with ... other medications for high-grade squamous intraepithelial lesions",
"criterion": "previous treatment with other medications for high-grade squamous intraepithelial lesions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Women treated previously with 5-fluorouracil",
"criterion": "previous treatment with 5-fluorouracil",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Women treated previously with ... imiquimod",
"criterion": "previous treatment with imiquimod",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Women treated previously with ... other medications for high-grade squamous intraepithelial lesions",
"criterion": "previous treatment with other medications for high-grade squamous intraepithelial lesions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Concurrent vaginal, vulvar, anal lesions or symptomatic infections",
"criterions": [
{
"exact_snippets": "Concurrent vaginal, vulvar, anal lesions",
"criterion": "lesions",
"requirement": {
"requirement_type": "location",
"expected_value": [
"vaginal",
"vulvar",
"anal"
]
}
},
{
"exact_snippets": "Concurrent vaginal, vulvar, anal lesions",
"criterion": "lesions",
"requirement": {
"requirement_type": "concurrent",
"expected_value": true
}
},
{
"exact_snippets": "symptomatic infections",
"criterion": "infections",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Concurrent vaginal, vulvar, anal lesions",
"criterion": "lesions",
"requirement": {
"requirement_type": "location",
"expected_value": [
"vaginal",
"vulvar",
"anal"
]
}
},
{
"exact_snippets": "Concurrent vaginal, vulvar, anal lesions",
"criterion": "lesions",
"requirement": {
"requirement_type": "concurrent",
"expected_value": true
}
}
]
},
{
"exact_snippets": "symptomatic infections",
"criterion": "infections",
"requirement": {
"requirement_type": "symptomatic",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Pregnant or planning pregnancy within the next 6 months, or breastfeeding; pregnant women are excluded from this study because 5-fluorouracil is an antimetabolite with the potential for teratogenic effects; because there is an unknown but potential risk for adverse events (AEs) in nursing infants secondary to treatment of the mother with 5-fluorouracil, breastfeeding should be discontinued if the mother is treated with 5-fluorouracil",
"criterions": [
{
"exact_snippets": "Pregnant or planning pregnancy within the next 6 months",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"not pregnant",
"not planning pregnancy within the next 6 months"
]
}
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Pregnant or planning pregnancy within the next 6 months",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"not pregnant",
"not planning pregnancy within the next 6 months"
]
}
},
{
"exact_snippets": "pregnant women are excluded from this study because 5-fluorouracil is an antimetabolite with the potential for teratogenic effects",
"criterion": "5-fluorouracil teratogenic risk",
"requirement": {
"requirement_type": "risk",
"expected_value": "teratogenic"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding status",
"requirement": {
"requirement_type": "status",
"expected_value": false
}
},
{
"exact_snippets": "because there is an unknown but potential risk for adverse events (AEs) in nursing infants secondary to treatment of the mother with 5-fluorouracil",
"criterion": "5-fluorouracil adverse events risk",
"requirement": {
"requirement_type": "risk",
"expected_value": "adverse events in nursing infants"
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Evidence of invasive anal, vulva, vaginal, or cervical carcinoma; prior loop electrosurgical excision procedure (LEEP) or ablative treatment within 6 months prior to study entry; other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years",
"criterions": [
{
"exact_snippets": "Evidence of invasive anal, vulva, vaginal, or cervical carcinoma",
"criterion": "invasive carcinoma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evidence of invasive anal, vulva, vaginal, or cervical carcinoma",
"criterion": "invasive carcinoma",
"requirement": {
"requirement_type": "location",
"expected_value": [
"anal",
"vulva",
"vaginal",
"cervical"
]
}
},
{
"exact_snippets": "prior loop electrosurgical excision procedure (LEEP) or ablative treatment within 6 months prior to study entry",
"criterion": "loop electrosurgical excision procedure (LEEP) or ablative treatment",
"requirement": {
"requirement_type": "time since procedure",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
},
{
"exact_snippets": "other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years",
"criterion": "other invasive malignancies",
"requirement": {
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
},
{
"exact_snippets": "other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years",
"criterion": "other invasive malignancies",
"requirement": {
"requirement_type": "exception",
"expected_value": "non-melanoma skin cancer"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Evidence of invasive anal, vulva, vaginal, or cervical carcinoma",
"criterion": "invasive carcinoma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Evidence of invasive anal, vulva, vaginal, or cervical carcinoma",
"criterion": "invasive carcinoma",
"requirement": {
"requirement_type": "location",
"expected_value": [
"anal",
"vulva",
"vaginal",
"cervical"
]
}
}
]
},
{
"exact_snippets": "prior loop electrosurgical excision procedure (LEEP) or ablative treatment within 6 months prior to study entry",
"criterion": "loop electrosurgical excision procedure (LEEP) or ablative treatment",
"requirement": {
"requirement_type": "time since procedure",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
},
{
"and_criteria": [
{
"exact_snippets": "other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years",
"criterion": "other invasive malignancies",
"requirement": {
"requirement_type": "time since diagnosis",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
},
{
"exact_snippets": "other invasive malignancies, with the exception of non-melanoma skin cancer, within the last 5 years",
"criterion": "other invasive malignancies",
"requirement": {
"requirement_type": "exception",
"expected_value": "non-melanoma skin cancer"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Pathologic findings consistent with",
"criterions": [
{
"exact_snippets": "Pathologic findings",
"criterion": "pathologic findings",
"requirement": {
"requirement_type": "consistency",
"expected_value": "consistent with"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Pathologic findings",
"criterion": "pathologic findings",
"requirement": {
"requirement_type": "consistency",
"expected_value": "consistent with"
}
}
]
}
},
{
"identified_line": {
"line": "* Atypical endometrial cells or serious glandular-cell atypia (atypical glandular cells, favor neoplasia cytology diagnosis)",
"criterions": [
{
"exact_snippets": "Atypical endometrial cells",
"criterion": "atypical endometrial cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "serious glandular-cell atypia",
"criterion": "serious glandular-cell atypia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "atypical glandular cells",
"criterion": "atypical glandular cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "favor neoplasia cytology diagnosis",
"criterion": "favor neoplasia cytology diagnosis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Atypical endometrial cells",
"criterion": "atypical endometrial cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "serious glandular-cell atypia",
"criterion": "serious glandular-cell atypia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "atypical glandular cells",
"criterion": "atypical glandular cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "favor neoplasia cytology diagnosis",
"criterion": "favor neoplasia cytology diagnosis",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Evidence of cervical carcinoma on Pap smear or biopsy",
"criterions": [
{
"exact_snippets": "Evidence of cervical carcinoma on Pap smear",
"criterion": "cervical carcinoma",
"requirement": {
"requirement_type": "evidence",
"expected_value": "Pap smear"
}
},
{
"exact_snippets": "Evidence of cervical carcinoma on ... biopsy",
"criterion": "cervical carcinoma",
"requirement": {
"requirement_type": "evidence",
"expected_value": "biopsy"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Evidence of cervical carcinoma on Pap smear",
"criterion": "cervical carcinoma",
"requirement": {
"requirement_type": "evidence",
"expected_value": "Pap smear"
}
},
{
"exact_snippets": "Evidence of cervical carcinoma on ... biopsy",
"criterion": "cervical carcinoma",
"requirement": {
"requirement_type": "evidence",
"expected_value": "biopsy"
}
}
]
}
},
{
"identified_line": {
"line": "* More than two cervical quadrants of CIN 3 as visualized by colposcopy",
"criterions": [
{
"exact_snippets": "More than two cervical quadrants of CIN 3",
"criterion": "cervical quadrants of CIN 3",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "quadrants"
}
}
},
{
"exact_snippets": "as visualized by colposcopy",
"criterion": "visualization by colposcopy",
"requirement": {
"requirement_type": "method",
"expected_value": "colposcopy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "More than two cervical quadrants of CIN 3",
"criterion": "cervical quadrants of CIN 3",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "quadrants"
}
}
},
{
"exact_snippets": "as visualized by colposcopy",
"criterion": "visualization by colposcopy",
"requirement": {
"requirement_type": "method",
"expected_value": "colposcopy"
}
}
]
}
},
{
"identified_line": {
"line": "* Nonvisual squamous columnar junction on colposcopy with no concurrent endocervical sampling performed",
"criterions": [
{
"exact_snippets": "Nonvisual squamous columnar junction on colposcopy",
"criterion": "squamous columnar junction visibility",
"requirement": {
"requirement_type": "visibility",
"expected_value": false
}
},
{
"exact_snippets": "no concurrent endocervical sampling performed",
"criterion": "endocervical sampling",
"requirement": {
"requirement_type": "performance",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Nonvisual squamous columnar junction on colposcopy",
"criterion": "squamous columnar junction visibility",
"requirement": {
"requirement_type": "visibility",
"expected_value": false
}
},
{
"exact_snippets": "no concurrent endocervical sampling performed",
"criterion": "endocervical sampling",
"requirement": {
"requirement_type": "performance",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* Use of other investigational agents within 6 months prior to enrollment",
"criterions": [
{
"exact_snippets": "Use of other investigational agents within 6 months prior to enrollment",
"criterion": "use of investigational agents",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Use of other investigational agents within 6 months prior to enrollment",
"criterion": "use of investigational agents",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
}
}
},
{
"identified_line": {
"line": "* History of allergic reactions attributed to compounds of similar chemical or biologic composition to 5-fluorouracil or imiquimod",
"criterions": [
{
"exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to 5-fluorouracil",
"criterion": "allergic reactions to compounds similar to 5-fluorouracil",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to ... imiquimod",
"criterion": "allergic reactions to compounds similar to imiquimod",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to 5-fluorouracil",
"criterion": "allergic reactions to compounds similar to 5-fluorouracil",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to ... imiquimod",
"criterion": "allergic reactions to compounds similar to imiquimod",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection (other than human papilloma virus [HPV]), symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements",
"criterions": [
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection (other than human papilloma virus [HPV])",
"criterion": "ongoing or active infection",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... symptomatic congestive heart failure",
"criterion": "symptomatic congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... psychiatric illness/social situations that would limit compliance with study requirements",
"criterion": "psychiatric illness/social situations",
"requirement": {
"requirement_type": "impact on compliance",
"expected_value": "would limit compliance with study requirements"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection (other than human papilloma virus [HPV])",
"criterion": "ongoing or active infection",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"not_criteria": {
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection (other than human papilloma virus [HPV])",
"criterion": "ongoing or active infection",
"requirement": {
"requirement_type": "presence",
"expected_value": "human papilloma virus [HPV]"
}
}
}
]
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... symptomatic congestive heart failure",
"criterion": "symptomatic congestive heart failure",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Uncontrolled intercurrent illness including, but not limited to, ... psychiatric illness/social situations that would limit compliance with study requirements",
"criterion": "psychiatric illness/social situations",
"requirement": {
"requirement_type": "impact on compliance",
"expected_value": "would limit compliance with study requirements"
}
}
]
}
},
{
"identified_line": {
"line": "* Subjects with known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"criterions": [
{
"exact_snippets": "known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"criterion": "dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"requirement": {
"requirement_type": "severity",
"expected_value": [
"partial",
"complete"
]
}
},
{
"exact_snippets": "known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"criterion": "dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"criterion": "dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"requirement": {
"requirement_type": "severity",
"expected_value": [
"partial",
"complete"
]
}
},
{
"exact_snippets": "known partial or complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"criterion": "dihydropyrimidine dehydrogenase (DPD) enzyme deficiency",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Agree to use an effective form of contraception; the effects of intravaginal 5-fluorocuracil and imiquimod on the developing human fetus at the recommended therapeutic dose are unknown; for this reason and because 5- fluorouracil is known to be teratogenic, women of child-bearing potential must agree to use adequate dual methods of contraception (hormonal method of birth control, intrauterine device, or tubal ligation - plus condoms) or abstinence prior to study entry and for the duration of study participation; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately",
"criterions": [
{
"exact_snippets": "Agree to use an effective form of contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "agreement",
"expected_value": true
}
},
{
"exact_snippets": "women of child-bearing potential must agree to use adequate dual methods of contraception (hormonal method of birth control, intrauterine device, or tubal ligation - plus condoms) or abstinence",
"criterion": "contraception method",
"requirement": {
"requirement_type": "type",
"expected_value": [
"hormonal method of birth control",
"intrauterine device",
"tubal ligation",
"abstinence"
]
}
},
{
"exact_snippets": "should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "notification",
"expected_value": "inform study physician immediately"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Agree to use an effective form of contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "agreement",
"expected_value": true
}
},
{
"or_criteria": [
{
"exact_snippets": "women of child-bearing potential must agree to use adequate dual methods of contraception (hormonal method of birth control, intrauterine device, or tubal ligation - plus condoms) or abstinence",
"criterion": "contraception method",
"requirement": {
"requirement_type": "type",
"expected_value": [
"hormonal method of birth control",
"intrauterine device",
"tubal ligation"
]
}
},
{
"exact_snippets": "women of child-bearing potential must agree to use adequate dual methods of contraception (hormonal method of birth control, intrauterine device, or tubal ligation - plus condoms) or abstinence",
"criterion": "contraception method",
"requirement": {
"requirement_type": "type",
"expected_value": "abstinence"
}
}
]
}
]
},
{
"exact_snippets": "should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "notification",
"expected_value": "inform study physician immediately"
}
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Inability to speak or read English or Spanish",
"criterions": [
{
"exact_snippets": "Inability to speak ... English or Spanish",
"criterion": "language ability",
"requirement": {
"requirement_type": "ability to speak",
"expected_value": [
"English",
"Spanish"
]
}
},
{
"exact_snippets": "Inability to ... read English or Spanish",
"criterion": "language ability",
"requirement": {
"requirement_type": "ability to read",
"expected_value": [
"English",
"Spanish"
]
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Prior hysterectomy",
"criterions": [
{
"exact_snippets": "Prior hysterectomy",
"criterion": "hysterectomy",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Use of anticoagulant medications",
"criterions": [
{
"exact_snippets": "Use of anticoagulant medications",
"criterion": "anticoagulant medications",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Subjects who have a known immunocompromised condition (HIV positive [+], use of immunosuppressive medications or systemic steroids, organ transplant recipients) or autoimmune conditions (e.g. psoriasis, rheumatoid arthritis or other known autoimmune conditions)",
"criterions": [
{
"exact_snippets": "known immunocompromised condition (HIV positive [+], use of immunosuppressive medications or systemic steroids, organ transplant recipients)",
"criterion": "immunocompromised condition",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "autoimmune conditions (e.g. psoriasis, rheumatoid arthritis or other known autoimmune conditions)",
"criterion": "autoimmune conditions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}